Silymarin versus hesperidin/diosmin for fibromyalgia symptom relief
Official title: The Effect of Silymarin Versus Hesperidin/Diosmin Combination on Patients With Fibromyalgia
Run by Ain Shams University · NCT07293767 · Data updated 2026-11-12
This project will test whether silymarin or a hesperidin/diosmin combination can ease symptoms in adults with fibromyalgia who continue to have pain despite conventional therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | November 16, 2024 |
| Main results expected | January 15, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07293767 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (age >18) with rheumatologist-confirmed fibromyalgia meeting the ACR 2016 criteria who continue to have symptoms despite conventional therapy and have not used Daflon or Legalon in the past six months.
✕Probably not a fit
Patients whose widespread pain is due to other inflammatory rheumatic disorders or neuropathic conditions, those allergic to silymarin/diosmin/hesperidin, or those with cognitive impairment preventing adherence are unlikely to benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with rheumatologist-confirmed fibromyalgia who meet the ACR 2016 criteria and have persistent symptoms despite conventional treatment will be assigned to receive silymarin (Legalon), a diosmin/hesperidin combination (Daflon), or no active treatment (control). Participants must be older than 18 and not have used Daflon or Legalon in the prior six months; those with other widespread inflammatory or neuropathic pain conditions or allergies to the study compounds are excluded. Symptoms and pain burden will be followed using standard fibromyalgia measures (including Widespread Pain Index and symptom severity scoring) over the treatment period. The trial is conducted at the Rheumatology outpatient unit of Ain Shams Hospitals in Cairo.
Why it matters
Potential benefit: If successful, readily available plant-derived therapies could reduce pain and fatigue and offer a lower-cost treatment option for some adults with fibromyalgia.
How similar studies have gone: Use of silymarin and diosmin/hesperidin for fibromyalgia is largely novel and well-controlled evidence in this condition is limited, so prior success is minimal.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed written consent. * Participant must meet the American College of Rheumatology 2016 revised classification criteria for Fibromyalgia: Widespread pain index (WPI) ≥ 7 and symptom severity (SS) scale score ≥ 5, or WPI 3 to 6 and SS scale score ≥ 9 * Age \>18 years old (males and females) * Diagnosis of FM confirmed by a rheumatologist. * Persistent pain syndrome on conventional therapy. * Not taking Daflon or Legalon for 6 months. Exclusion Criteria: * Pain due to other conditions (e.g. diabetic peripheral neuropathic pain or post-herpetic neuralgia) that would confound assessment or self-evaluation of the pain associated with FM. * Patients with pain due to any widespread inflammatory musculoskeletal disorder (e.g. rheumatoid arthritis, lupus) or widespread rheumatic disease other than FM. * Allergy to silymarin or diosmin or hesperidin. * Cognitive deficits that could impair understanding of the study, completion of questionnaires, or adherence to therapy. * Pregnant or planning pregnancy women and breastfeeding women. * Major comorbidities like renal impairment, severe liver disease, chronic hepatitis C, history of alcohol or drug addiction. * Current severe or uncontrolled major depressive disorder or anxiety disorders. * Patients will be excluded if there is no compliance to the medication.
Where it's running
-
Outpatients clinic of department of Internal medicine- Rheumatology unit Ain shams hospitals.
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: menna s teaching assistant of clinical pharmacy/ master's student
- Email: mssalama@msa.edu.eg
- Phone: 01064897439
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Dietary strategies to help fibromyalgia in overweight or obese women
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
-
Isokinetic microdose exercise for women with fibromyalgia
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
-
Does hardaliye help fibromyalgia when added to a personalized diet?
This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.